- •Preface
- •Contents
- •List of Abbreviations
- •Antibacterial Agents
- •A. TOPICAL ANTIBIOTICS
- •B. ORAL ANTIBIOTICS
- •C. ANTIBIOTICS FOR SUBCONJUNCTIVAL/INTRAVITREAL INJECTION
- •D. REGIMENS FOR SPECIFIC ORGANISMS
- •E. REGIMENS FOR SPECIFIC CLINICAL ENTITIES
- •7 Dacryocystitis
- •Antifungal Agents
- •A. AGENTS
- •B. SPECIFIC ANTI-FUNGAL REGIMENS
- •2 Molds
- •3 Dimorphic Fungi
- •Antiviral Agents
- •A. TOPICAL
- •B. SYSTEMIC
- •Anti-Parasitic Agents
- •A. PROTOZOA
- •B. HELMINTHS
- •Anti-Glaucoma Agents
- •D. HYPEROSMOLAR AGENTS
- •H. COMBINATION AGENTS
- •I. SPECIFIC REGIMENTS
- •2 Elevated Eye Pressure During Pregnancy
- •Neuro-Ophthalmology
- •A. AGENTS USED IN NEURO-OPHTHALMOLOGY
- •B. SPECIFIC REGIMENS
- •Anti-Inflammatory Agents
- •A. STEROIDAL
- •B. COMBINATION STEROID WITH ANTIBIOTIC
- •C. NONSTEROIDAL
- •D. MISCELLANEOUS
- •Mydriatics, Cycloplegics, and Reversal Agents
- •Lubricants and Viscoelastics
- •A. ARTIFICIAL TEARS, VISCOELASTICS, AND LUBRICATING OINTMENTS
- •Low Viscosity
- •High Viscosity
- •Unknown Viscosity
- •Insert
- •Gels & Ointments
- •Ointments
- •Gels
- •Viscoelastics
- •B. IRRIGATING SOLUTIONS
- •Miscellaneous
- •A. AGENTS FOR RELIEF OF SEASONAL ALLERGIC CONJUNCTIVITIS/OCULAR DISCOMFORT
- •B. OCULAR DECONGESTANTS
- •C. TOPICAL HYPEROSMOLAR AGENTS
- •D. VITAMINS
- •E. ANESTHETIC AGENTS
- •F. HOMEOPATHIC DRUGS
- •G. CAPSULE STAINING ADJUNCTS
- •H. MISCELLANEOUS
- •I. DRUGS FOR HYPHEMA
- •Anti-Angiogenesis Agents
- •Contact Lens Solutions
- •Contact Lens Solution Hypersensitivity
- •Soft Contact Lens Solutions
- •I. LISTING OF SOFT LENS PRODUCTS BY CATEGORY
- •A. Daily Cleaners
- •B. Enzymatic Cleaners
- •C. Daily Protein Removers
- •D. Rewetting/Lubricating Drops
- •E. Oxidation Solutions/Systems
- •F. Saline Solutions
- •G. Combination Solutions
- •II. SOFT LENS PRODUCTS LISTED BY SYSTEM AND MANUFACTURER: NOT ALL PRODUCTS ARE LISTED IN THIS SECTION BECAUSE NOT ALL PRODUCTS BELONG TO A PARTICULAR SYSTEM
- •Rigid Lens Solutions
- •I. LISTING OF RIGID LENS RODUCTS BY CATEGORY
- •A. Daily Cleaners
- •C. Daily Protein Remover
- •D. Oxidation Systems
- •E. Storage and Disinfection
- •F. Wetting/Rewetting
- •G. Combination Solutions
- •APPENDIX 1: TOPICAL ANTIBACTERIAL SPECTRUM
- •APPENDIX 2: A PREPARING FORTIFIED TOPICAL ANTIBIOTICS AND PREPARING ORAL ACETAZOLAMIDE SOLUTION
- •Fortified Bacitracin
- •Fortified Cefazolin
- •Fortified Vancomycin
- •APPENDIX 3: ANTI-FUNGAL ACTIVITY SPECTRUM
- •APPENDIX 4: RENAL DOSING FOR SELECTED DRUGS
- •Cidofovir Dosing in Renal Failure*
- •Famciclovir Dosing in Renal Failure*
- •Foscarnet Dosing in Renal Failure*
- •Intravenous Ganciclovir Dosing in Renal Failure*
- •Oral Ganciclovir Dosing in Renal Failure*
- •Valacyclovir Dosing in Renal Failure*
- •APPENDIX 5: GLAUCOMA MEDICATION PRESERVATIVES
- •APPENDIX 6: TITRATING TOPICAL DROPS FOR CHILDREN
- •Product Index
- •Subject Index
Gels |
|
|
|
|
|
86 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade Name |
|
|
Notes |
|
|
|
|
|
|
|
|
|
|
|
|||
GenTeal Lubricant Eye GelO |
contains carbopol 980, claimed to transform from gel to liquid upon contact with the eye |
|||||||
Night & Day Tears Again Sterile |
contains povidone 0.1% therefore is not recommended for people with iodine allergies; preserved |
|||||||
Lubricant Gel |
|
|
with benzalkonium chloride; not recommended for contact lens wearing patients |
|||||
|
|
|
|
|
|
|
|
|
Viscoelastics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
SH = sodium hyaluronate |
|
adapative: molecules fracture when exposed to high shear rates |
||||||
HMC = hydroxymethylcellulose |
|
|
|
|
|
|
||
CS = chondroitin sulfate |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cohesive versus |
|||
Trade Name |
Component |
Viscosity |
Molecular Weight |
Dispersive |
||||
|
|
|
|
|
|
|
||
Amvisc |
1.2% |
SH |
40,000 cSt (62,000 cp+) |
2,000,000 daltons |
cohesive |
|||
Amvisc Plus |
1.6% |
SH |
55,000 cSt (82,000 cp+) |
1,500,000 daltons |
cohesive |
|||
BioLon |
1.0% |
SH |
215,000 cpsD |
3,000,000 daltons |
cohesive |
|||
Cellugel |
2.0% |
HMC |
20,000–40,000 cps |
300,000 daltons |
dispersive |
|||
CoEase |
1.2% |
SH |
40,000 cps |
1,000,000 daltons |
cohesive |
|||
DuoVisc |
|
|
|
|
|
|
|
|
EyeVisc |
2.0% HMC |
4,000 cps |
Unknown |
dispersive |
||||
EyeVisc Plus |
2.0% |
HMC |
40,000 cps |
Unknown |
dispersive |
|||
EyeVisc SH |
1.4% SH |
50,000 cps |
Unknown |
cohesive |
||||
Healon |
1.0% |
SH |
200,000 cp+ |
4,000,000 daltons |
cohesive |
|||
HealonGV |
1.4% |
SH |
2,000,000 cp+ |
5,000,000 daltons |
cohesive |
Healon 5 |
2.3% |
SH |
7,000,000 cp |
4,000,000 daltons |
cohesive |
|
|
|
|
|
possibly |
|
|
|
|
|
adaptive |
LensVisc MC |
2.0% |
HMC |
4,000 mPas |
86,000 daltons |
dispersive |
LensVisc HA |
2.0% |
SH |
>10,000 mPas |
2,300,000 daltons |
cohesive |
Occu-Lon |
1.5% |
SH |
50,000 cps |
2,000,000 daltons |
|
Ocucoat |
2.0% |
HMC |
4,000 cp+ |
80,000 daltons |
dispersive |
Provisc |
1.0% |
SH |
135,000 cp+ |
1,900,000 daltons |
cohesive |
STAARVisc II |
1.2% |
SH |
40,000 cps |
|
cohesive |
UniVisc |
1.0% |
SH |
Unknown |
3,000,000 daltons |
cohesive |
Viscoat |
3.0% SH and 4% CS |
50,000 cp+ |
22,500 daltons for chondroitin sulfate and |
dispersive |
|
|
in a 3:1 ratio |
|
500,000 daltons sodium hyaluronate |
|
|
Vitrax |
3.0 % SH |
35,000 cp+ |
500,000 daltons |
dispersive |
|
+37 C shear rate 0/sec (provided by Pharmacia advertisement)
++Measured on Brookfield Digital Cone and Plate Viscometer (provided by CIBA file data) Dprovided by Akorn file data
*37 C measured on Cannon-Fenske Viscometer (provided by Stortz advertisement) **25 C shear rate 2.6/sec (provided by Allergan file data)
***25 C measured on Brookfield Digital Cone and Plate Viscometer (provided by Alcon file data) y25 C measured on Brookfield Digital Cone and Plate Viscometer (provided by Ross file data) yy25 C measured on Brookfield Digital Cone and Plate Viscometer (provided by Fougera file data) ¥Provided by Allergan file data
xShear rate 2/sec (provided by Mentor file data) xxProvided by Shah & Shah IOL Ltd.
#Provided by Bausch & Lomb file data ##Provided by Akorn file data AProvided by Alimera Sciences, Inc.
Lubricants and Viscoelastics 87
